Founders Fund

Founders Fund is a San Francisco-based venture capital firm that backs science and technology companies across multiple stages, from seed to late-stage. It pursues transformative technologies and follows a founder-friendly investment approach that provides substantial support with minimal interference. The firm invests in ventures solving difficult problems across sectors such as aerospace and transportation, artificial intelligence, advanced computing, energy, healthcare, biotechnology, cybersecurity, fintech, consumer internet, software, robotics, and related technology fields. It has backed notable companies early, including SpaceX, Palantir, and Facebook, reflecting a history of partnering with ambitious founders to scale breakthrough technologies.

Lauren Gross

Partner and COO

Bridget Harris

Associate

Joey Krug

Partner

Jeffrey Lonsdale

Managing Director, Asia

John Luttig

Partner

Past deals in Healthcare

Ataraxis

Series A in 2025
Ataraxis is an AI-based diagnostic platform that helps develop personalized treatment plans.

Network Bio

Seed Round in 2025
Network Bio develops a platform that serves as a centralized repository for clinical and molecular data. This enables researchers to identify patterns and correlations, facilitating precision medicine approaches for common human diseases.

Nucleus

Series A in 2025
Nucleus operates a biotechnology research platform focused on next-generation consumer genetic testing and analysis. The company allows users to upload their genetic information obtained from established providers and employs proprietary algorithms to calculate polygenic risk scores and assess disease risk based on genetic variants. Utilizing whole-genome sequencing, Nucleus delivers comprehensive genetic analysis, facilitating advancements in human health and medicine. The results are presented on a user-friendly platform, making complex genetic information accessible and understandable for users.

Safely You

Series C in 2025
SafelyYou, Inc. is a technology company based in Berkeley, California, founded in 2015, that specializes in artificial intelligence software designed for managed Alzheimer's care. The company focuses on fall prevention by utilizing a camera system installed in patients' rooms to detect falls in real time and alert caregivers. Its AI-enabled technology analyzes patterns and signs that may indicate a potential fall, allowing for proactive intervention. SafelyYou's solutions aim to enhance the safety and well-being of individuals with Alzheimer's and other forms of dementia, facilitating improved medication adherence, behavioral monitoring, and overall care management in skilled nursing facilities and assisted living communities. By reducing the frequency and impact of falls, SafelyYou contributes to lowering hospitalization rates among this vulnerable population.

Even

Series A in 2024
Even partners with top hospitals nationwide to offer unlimited diagnostics, consultations, and hospitalization coverage worth INR 50 lakhs via a single monthly subscription.

EnClear Therapies

Venture Round in 2024
EnClear Therapies develops device-based therapies for treating neurodegenerative diseases by removing toxic proteins from cerebrospinal fluid. Its initial targets are Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP). Incorporated in 2018, the company is based in Newburyport, Massachusetts.

Q Bio

Venture Round in 2024
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

9amHealth

Series A in 2024
9amHealth is a healthcare service provider that aims to deliver comprehensive medical support for chronic conditions such as diabetes, hypertension, and hyperlipidemia. The company offers personalized care plans, prescription medication, at-home lab tests, and unlimited virtual visits, ensuring that patients have direct access to affordable and compassionate care. By redesigning all care elements into a single digital service, 9amHealth caters to the modern realities of patients' lives, making healthcare always available and convenient, even for those without insurance. Its focus on chronic conditions highlights its commitment to improving the health and well-being of customers in the United States.

Forward

Series E in 2023
Forward is a startup focused on transforming healthcare delivery by incorporating advanced technologies that have been underutilized in the industry, such as sensors, mobile applications, and artificial intelligence. Founded in January 2016 by former executives from Google and Uber, Forward operates primary care clinics that emphasize personalized patient care. Through its mobile application and natural language processing system, the company enhances healthcare services, offering features like body scanning, genetic screening, real-time blood testing, and home monitoring of vital signs. These innovations empower patients to take control of their health, promote transparency, and foster better collaboration with their primary care physicians. Backed by prominent investors and entrepreneurs, Forward aims to redefine the patient experience in healthcare.

Mendaera

Series A in 2023
Mendaera is a medtech startup specializing in advanced healthcare technologies, focusing on robotics and diagnostic tools. Its platform integrates robotics, AI, real-time imaging, and connectivity to enable consistent medical interventions at scale, aiming to make high-quality care accessible to all patients.

Earable Neuroscience

Convertible Note in 2023
Earable Neuroscience is a deep tech company focusing on building consumer wearables and solutions that unlock human potential through improved sleep and cognitive function. Earable was early-invested in by FoundersFund and Samsung Ventures. After 9 years of R&D at the University of Colorado and the University of Oxford, Earable invented FRENZ Brainband - a pioneering AI-powered sleep-aid wearable designed to track and stimulate brain activity in real time using science-backed personalized audio delivered via bone-conduction speakers.

Siren Biotechnology

Seed Round in 2023
Siren Biotechnology is a biotechnology company focused on cancer treatment through an integrated therapeutic modality that combines adeno-associated virus–based gene therapy with cytokine immunotherapy. The approach delivers targeted cytokines to tumors, aiming to activate both innate and adaptive immune responses while addressing toxicity and off-target effects. By uniting gene delivery with immunotherapy in a single modality, the company seeks to enhance tumor cell elimination and improve long-term anti-tumor immunity, potentially reducing recurrence in cancer patients.

NewLimit

Series A in 2023
NewLimit focuses on developing epigenetic reprogramming medicines to treat age-related diseases and extend the human health span. It uses single-cell genomics, machine learning, and functional assays to identify epigenetic targets and develop messenger RNA-based therapies for improving metabolic function in liver cells.

Even

Convertible Note in 2022
Even partners with top hospitals nationwide to offer unlimited diagnostics, consultations, and hospitalization coverage worth INR 50 lakhs via a single monthly subscription.

Fathom

Series B in 2022
Fathom Health, founded in 2016 and based in San Francisco, California, provides artificial intelligence solutions aimed at streamlining the medical reimbursement process. The company has developed a coding automation platform that expedites medical coding practices by automatically reviewing incoming charts. In addition to this technology, Fathom offers full-service coding solutions and real-time comprehensive audits, allowing healthcare providers to enhance operational efficiency through automation. By leveraging AI, Fathom enables medical operators to optimize their coding processes, ultimately improving their business outcomes.

Dr. B

Venture Round in 2022
Dr. B is a telehealth service that facilitates remote consultations with board-certified doctors for prescription medications. Patients can obtain affordable prescriptions for treatments like Paxlovid from home, then fill them at their preferred pharmacy or online. Dr. B also offers free services to eligible patients.

Modern Animal

Series C in 2022
Modern Animal is a veterinary platform and clinic operator based in Los Angeles that combines in-clinic care with at-home services and a mobile app. The company provides general and preventive veterinary care, including wellness visits, vaccinations, parasite prevention, routine labs, dental care, and surgeries such as spays and mass removals, along with diagnostics like ultrasound and radiology, and nutritional and behavioral assessments. Through its platform, clients can access unlimited exams, 24/7 virtual care, in-app prescription requests and delivery, and flexible options such as walk-in and drop-off visits. The business supports a membership model designed to deepen relationships among doctors, pets and owners while leveraging technology and design to improve access, convenience and the overall pet-care experience.

Nucleus

Seed Round in 2022
Nucleus operates a biotechnology research platform focused on next-generation consumer genetic testing and analysis. The company allows users to upload their genetic information obtained from established providers and employs proprietary algorithms to calculate polygenic risk scores and assess disease risk based on genetic variants. Utilizing whole-genome sequencing, Nucleus delivers comprehensive genetic analysis, facilitating advancements in human health and medicine. The results are presented on a user-friendly platform, making complex genetic information accessible and understandable for users.

MyOme

Series B in 2022
MyOme develops a genetic testing technology that provides comprehensive health insights through whole genome sequencing. Its platform offers detailed reports on disease risk and medication response, accompanied by independent physician reviews and genetic counseling. The company ensures ongoing updates using advanced technologies, empowering individuals to make informed health decisions while maintaining data privacy and security.

Ostro

Series B in 2022
Ostro is a health platform based in Miami, Florida, founded in 2019, that specializes in personalized engagement solutions for the life sciences sector. The company focuses on creating informative connections between medicine producers and consumers, enhancing healthcare experiences for both patients and healthcare professionals. Ostro's platform streamlines the patient journey, offering services such as virtual consultations, logistics, regulatory compliance, and integrated payment solutions. By personalizing healthcare journeys, Ostro aims to boost engagement and improve the overall health outcomes for millions of individuals while delivering value to life sciences brands.

9amHealth

Series A in 2022
9amHealth is a healthcare service provider that aims to deliver comprehensive medical support for chronic conditions such as diabetes, hypertension, and hyperlipidemia. The company offers personalized care plans, prescription medication, at-home lab tests, and unlimited virtual visits, ensuring that patients have direct access to affordable and compassionate care. By redesigning all care elements into a single digital service, 9amHealth caters to the modern realities of patients' lives, making healthcare always available and convenient, even for those without insurance. Its focus on chronic conditions highlights its commitment to improving the health and well-being of customers in the United States.

Alinea Health

Venture Round in 2022
Alinea Health is a health-tech startup that provides solutions for corporate health. It utilizes large amounts of data and proprietary algorithms to assist the client company's beneficiaries in navigating their health plans, providing personalized and unbiased guidance, recommendations from the most effective doctors in the accredited network, and conveniences such as scheduling consultations and exams. In addition to continuous monitoring, its doctors use the Lifestyle Medicine methodology to promote a healthy lifestyle and lower the risk of developing chronic diseases.

SmithRx

Series B in 2022
Founded in San Francisco in 2016, SmithRx specializes in designing and managing custom pharmacy benefit plans for companies. It leverages a modern technology platform to deliver flexibility, efficiency, and customer satisfaction, aligning incentives through data analytics.

Balanced

Seed Round in 2022
Balanced is a digital fitness company focused on healthy aging for older adults. It provides live exercise and mindfulness classes delivered via video, including Zoom, and offers a digital platform with physical therapy assessments, personalized workout schedules, and aging-focused fitness guidance. Founded in 2021 and headquartered in New York, United States, Balanced aims to help older adults maintain a healthy lifestyle through accessible, structured fitness and wellness programs.

Earable Neuroscience

Seed Round in 2022
Earable Neuroscience is a deep tech company focusing on building consumer wearables and solutions that unlock human potential through improved sleep and cognitive function. Earable was early-invested in by FoundersFund and Samsung Ventures. After 9 years of R&D at the University of Colorado and the University of Oxford, Earable invented FRENZ Brainband - a pioneering AI-powered sleep-aid wearable designed to track and stimulate brain activity in real time using science-backed personalized audio delivered via bone-conduction speakers.

Garner Health

Series B in 2021
Garner Health is a technology company established in 2019 and based in New York, NY, that focuses on enhancing the healthcare experience for employees through employer partnerships. By leveraging a doctor quality analytics platform, Garner Health provides insights into clinical quality and total care costs, helping employers direct their employees to high-quality healthcare providers. The platform also offers an overlay account that covers employee deductibles and coinsurance, allowing employees to reduce out-of-pocket expenses while ensuring employers achieve guaranteed savings. Through this approach, Garner Health aims to improve healthcare quality and affordability for both employees and their employers.

Sword Health

Series D in 2021
Sword Health specializes in digital health solutions for physical rehabilitation. It employs artificial intelligence to deliver personalized care globally, enabling patients to perform interactive exercises at home under remote physiotherapist supervision.

Contraline

Series A in 2021
Contraline, Inc. is a biotechnology company based in Charlottesville, Virginia, focused on developing innovative male birth control solutions. The company is pioneering the first long-lasting, non-hormonal, and reversible contraceptive for men. Its primary product, Echo-V, is an ultrasound-visible polymer solution that is injected into the vas deferens, forming a polymer hydrogel device. This device functions as a semi-permeable membrane, effectively blocking sperm while allowing bodily fluids to pass through. Contraline also offers Vasintomy, a non-surgical procedure for the insertion of Echo-V, providing a cost-effective and accessible approach to male contraception. Incorporated in 2015, Contraline aims to transform the landscape of reproductive health for men.

Elemy

Series B in 2021
Elemy is a nationwide provider of childhood behavioral and mental healthcare, specializing in autism care since its launch in April 2020. The company has expanded its services to address a range of developmental and mental health issues, including ADHD, OCD, depression, and social anxiety. Elemy employs a technology-driven care model that modernizes traditional systems by offering in-home and online Applied Behavior Analysis (ABA) services. This approach enhances accessibility and clinical outcomes while reducing costs. The platform features free autism assessments and matches children with therapists to create individualized treatment plans tailored to their specific needs. Elemy's multidisciplinary clinical team oversees an integrated care model, demonstrating significant improvements in behavior for many children.

Teiko.bio

Venture Round in 2021
Founded in 2020, Teiko.bio is a Salt Lake City-based company that provides an immune profiling platform. This platform supports global clinical trials by offering blood preservation kits, cytometry panels, data reports, and tailored gating services. It enables clinicians to make informed decisions regarding patient response.

9amHealth

Seed Round in 2021
9amHealth is a healthcare service provider that aims to deliver comprehensive medical support for chronic conditions such as diabetes, hypertension, and hyperlipidemia. The company offers personalized care plans, prescription medication, at-home lab tests, and unlimited virtual visits, ensuring that patients have direct access to affordable and compassionate care. By redesigning all care elements into a single digital service, 9amHealth caters to the modern realities of patients' lives, making healthcare always available and convenient, even for those without insurance. Its focus on chronic conditions highlights its commitment to improving the health and well-being of customers in the United States.

Safely You

Series A in 2021
SafelyYou, Inc. is a technology company based in Berkeley, California, founded in 2015, that specializes in artificial intelligence software designed for managed Alzheimer's care. The company focuses on fall prevention by utilizing a camera system installed in patients' rooms to detect falls in real time and alert caregivers. Its AI-enabled technology analyzes patterns and signs that may indicate a potential fall, allowing for proactive intervention. SafelyYou's solutions aim to enhance the safety and well-being of individuals with Alzheimer's and other forms of dementia, facilitating improved medication adherence, behavioral monitoring, and overall care management in skilled nursing facilities and assisted living communities. By reducing the frequency and impact of falls, SafelyYou contributes to lowering hospitalization rates among this vulnerable population.

HeartLab

Seed Round in 2021
HeartLab develops an AI-powered cardiology imaging platform that integrates the end-to-end imaging workflow. The company builds diagnostic tools that analyze echocardiograms and other cardiac imaging to help doctors diagnose and treat cardiovascular disease. Its tools automate repetitive measurements, enabling faster interpretation and improved efficiency for clinicians, with the goal of advancing cardiology care globally.

Mindbloom

Series A in 2021
Mindbloom is a mental health and wellness platform that provides at-home, clinician-prescribed psychedelic therapies, including guided ketamine sessions, to help individuals address anxiety and depression and improve overall well-being. The service pairs clients with licensed clinicians who review health history to determine suitability and guide treatment, ensuring physician oversight. The platform combines science-backed medicines designed by psychiatrists with behavioral science-based engagement and personalized media to support personal growth and sustained well-being. Mindbloom serves individual users and enterprise partners, and pursues research collaborations with academic institutions to advance understanding of digital and psychedelic therapies.

Calibrate

Series B in 2021
Calibrate Health, Inc., established in 2020 and based in New York, specializes in digital metabolic health services for sustainable weight loss. The company combines FDA-approved metabolic medications with a comprehensive curriculum and personalized virtual coaching to address the root causes of weight issues and promote long-term behavior change. Calibrate's approach, led by experts in obesity and nutrition science, aims to improve metabolic health and drive lasting results.

Modern Animal

Series A in 2021
Modern Animal is a veterinary platform and clinic operator based in Los Angeles that combines in-clinic care with at-home services and a mobile app. The company provides general and preventive veterinary care, including wellness visits, vaccinations, parasite prevention, routine labs, dental care, and surgeries such as spays and mass removals, along with diagnostics like ultrasound and radiology, and nutritional and behavioral assessments. Through its platform, clients can access unlimited exams, 24/7 virtual care, in-app prescription requests and delivery, and flexible options such as walk-in and drop-off visits. The business supports a membership model designed to deepen relationships among doctors, pets and owners while leveraging technology and design to improve access, convenience and the overall pet-care experience.

Modern Animal

Series B in 2021
Modern Animal is a veterinary platform and clinic operator based in Los Angeles that combines in-clinic care with at-home services and a mobile app. The company provides general and preventive veterinary care, including wellness visits, vaccinations, parasite prevention, routine labs, dental care, and surgeries such as spays and mass removals, along with diagnostics like ultrasound and radiology, and nutritional and behavioral assessments. Through its platform, clients can access unlimited exams, 24/7 virtual care, in-app prescription requests and delivery, and flexible options such as walk-in and drop-off visits. The business supports a membership model designed to deepen relationships among doctors, pets and owners while leveraging technology and design to improve access, convenience and the overall pet-care experience.

Even

Seed Round in 2021
Even partners with top hospitals nationwide to offer unlimited diagnostics, consultations, and hospitalization coverage worth INR 50 lakhs via a single monthly subscription.

Sword Health

Series C in 2021
Sword Health specializes in digital health solutions for physical rehabilitation. It employs artificial intelligence to deliver personalized care globally, enabling patients to perform interactive exercises at home under remote physiotherapist supervision.

Clearing

Seed Round in 2021
Clearing is a digital healthcare platform built to serve the more than 50M chronic pain sufferers in the United States. In partnership with leading physicians and researchers at Harvard, Johns Hopkins, and the Hospital for Special Surgery, and with significant funding from top-tier investors Bessemer Venture Partners, Founders Fund, Breyer Capital, and a host of leading healthcare and consumer entrepreneurs (including the founders of Hims, Seamless Grubhub, Flatiron Health, Forward Health, Curology and more) we are on a mission to provide patients with access to comprehensive, opioid-free pain relief.

Collective Health

Series F in 2021
Collective Health provides a cloud-based health benefits platform that unifies medical, dental, vision, pharmacy, and related programs into a single administration experience, helping employers simplify benefits, guide employees in understanding and navigating care, and manage costs and outcomes. The platform offers integrated administration of all health plans through one portal, with live concierge support and digital tools to find and manage care, and connects employees with medical, pharmacy, dental, and vision providers. Headquartered in San Francisco with offices in Chicago and Lehi, it aims to reduce the administrative burden of delivering benefits while improving member experience and overall health outcomes.

Seed Health

Series A in 2021
Seed Health is a biotechnology company focused on therapeutics, consumer health innovations, and environmental solutions grounded in microbial sciences. It collaborates with academic researchers to advance discoveries in microbiology and develops health supplements that employ live biotherapeutics, combining probiotics and prebiotics to support digestive health, skin health, heart health, and micronutrient synthesis.

Seed Health

Series A in 2021
Seed Health is a biotechnology company focused on therapeutics, consumer health innovations, and environmental solutions grounded in microbial sciences. It collaborates with academic researchers to advance discoveries in microbiology and develops health supplements that employ live biotherapeutics, combining probiotics and prebiotics to support digestive health, skin health, heart health, and micronutrient synthesis.

Multiply Labs

Series A in 2021
Multiply Labs develops robotic-enabled manufacturing for personalized pharmaceutical capsules, combining pharmaceutical science with robotics to produce tailor-made capsules that align with individual patient metabolic needs. The company operates a robotic manufacturing facility and has introduced 3D-printed capsules, aiming to address scaling challenges in biotech and improve the efficiency and cost of producing patient-specific medicines.

Elemy

Series A in 2021
Elemy is a nationwide provider of childhood behavioral and mental healthcare, specializing in autism care since its launch in April 2020. The company has expanded its services to address a range of developmental and mental health issues, including ADHD, OCD, depression, and social anxiety. Elemy employs a technology-driven care model that modernizes traditional systems by offering in-home and online Applied Behavior Analysis (ABA) services. This approach enhances accessibility and clinical outcomes while reducing costs. The platform features free autism assessments and matches children with therapists to create individualized treatment plans tailored to their specific needs. Elemy's multidisciplinary clinical team oversees an integrated care model, demonstrating significant improvements in behavior for many children.

Forward

Series D in 2021
Forward is a startup focused on transforming healthcare delivery by incorporating advanced technologies that have been underutilized in the industry, such as sensors, mobile applications, and artificial intelligence. Founded in January 2016 by former executives from Google and Uber, Forward operates primary care clinics that emphasize personalized patient care. Through its mobile application and natural language processing system, the company enhances healthcare services, offering features like body scanning, genetic screening, real-time blood testing, and home monitoring of vital signs. These innovations empower patients to take control of their health, promote transparency, and foster better collaboration with their primary care physicians. Backed by prominent investors and entrepreneurs, Forward aims to redefine the patient experience in healthcare.

Modern Health

Series D in 2021
Modern Health is a mental wellness platform designed for innovative companies to support the mental health of their employees. The platform offers a comprehensive suite of services including therapy sessions, coaching, and self-guided courses, all accessible through a user-friendly app. Modern Health combines the WHO well-being assessment with self-service wellness kits and connects users with certified coaches and licensed therapists in 35 languages. By providing these resources, Modern Health aims to destigmatize mental health conversations and make services more accessible, ultimately improving employee well-being and productivity.

Garner Health

Series A in 2021
Garner Health is a technology company established in 2019 and based in New York, NY, that focuses on enhancing the healthcare experience for employees through employer partnerships. By leveraging a doctor quality analytics platform, Garner Health provides insights into clinical quality and total care costs, helping employers direct their employees to high-quality healthcare providers. The platform also offers an overlay account that covers employee deductibles and coinsurance, allowing employees to reduce out-of-pocket expenses while ensuring employers achieve guaranteed savings. Through this approach, Garner Health aims to improve healthcare quality and affordability for both employees and their employers.

Sword Health

Series B in 2021
Sword Health specializes in digital health solutions for physical rehabilitation. It employs artificial intelligence to deliver personalized care globally, enabling patients to perform interactive exercises at home under remote physiotherapist supervision.

Peptilogics

Series B in 2020
Peptilogics, Inc. is a clinical-stage biotechnology company based in West Mifflin, Pennsylvania, founded in 2013. The company specializes in designing and developing novel peptide therapeutics aimed at addressing the urgent challenge of multidrug-resistant bacterial infections. Peptilogics utilizes a unique computational platform that enhances drug discovery by exploring new chemical design spaces while ensuring the biological viability and manufacturability of potential therapeutics. Their lead candidate, PLG0206, is a broad-spectrum anti-infective peptide that targets prosthetic joint infections and has received both FDA Orphan Drug Designation and Qualified Infectious Disease Product Designation. Through its innovative eCAP (engineered cationic antibiotic peptide) platform, Peptilogics aims to provide effective treatment options against resistant bacteria and biofilms, ultimately improving patient outcomes and affordability in healthcare.

Oscar Health

Venture Round in 2020
Oscar Health is a health insurance company based in New York, founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser. It specializes in offering individual and family health insurance plans, Medicare Advantage programs for seniors, and small group products. Oscar Health aims to enhance the healthcare experience by leveraging technology, design, and data to make services more accessible and user-friendly. The company primarily serves individuals, couples, and families who do not receive employer-sponsored health insurance in select states, including New York, New Jersey, California, and Texas. In addition to traditional insurance offerings, Oscar provides virtual care, doctor support, and appointment scheduling, emphasizing a comprehensive approach to healthcare management.

Modern Health

Series C in 2020
Modern Health is a mental wellness platform designed for innovative companies to support the mental health of their employees. The platform offers a comprehensive suite of services including therapy sessions, coaching, and self-guided courses, all accessible through a user-friendly app. Modern Health combines the WHO well-being assessment with self-service wellness kits and connects users with certified coaches and licensed therapists in 35 languages. By providing these resources, Modern Health aims to destigmatize mental health conversations and make services more accessible, ultimately improving employee well-being and productivity.

Rational Vaccines

Series A in 2020
Rational Vaccines is a biotechnology company focused on developing vaccines for herpes simplex virus (HSV) and related diseases. It aims to revolutionize treatment, prevention, and diagnosis by creating rationally engineered, live-attenuated viral vaccines.

HeartLab

Seed Round in 2020
HeartLab develops an AI-powered cardiology imaging platform that integrates the end-to-end imaging workflow. The company builds diagnostic tools that analyze echocardiograms and other cardiac imaging to help doctors diagnose and treat cardiovascular disease. Its tools automate repetitive measurements, enabling faster interpretation and improved efficiency for clinicians, with the goal of advancing cardiology care globally.

Cedar

Series C in 2020
Cedar is a patient payment and engagement platform designed for hospitals, health systems, and medical groups to enhance the overall patient experience. Founded in 2016 and headquartered in New York, the platform utilizes advanced data science to streamline and personalize the billing process. By consolidating billing information from various caregivers, Cedar provides clear invoices that detail patient obligations while offering user-friendly click-to-pay options. This modern approach not only simplifies the payment experience but also supports healthcare providers in improving their billing operations and fostering better patient engagement.

Siren Care

Series B in 2020
Siren Care develops wearable health technology for diabetic foot health monitoring. The company offers Siren diabetic socks and a foot temperature monitoring system that continuously tracks foot temperature to detect early signs of inflammation and diabetic foot ulcers, helping prevent complications such as amputations. Data from the socks can be accessed via a mobile application and shared with providers, including podiatrists, to support monitoring and timely intervention. It serves patients and healthcare providers through its flagship Siren Diabetic Foot Program. Founded in 2015 and based in San Francisco, Siren Care focuses on proactive foot health management for individuals at risk of diabetic foot complications.

AbCellera

Series B in 2020
AbCellera is an antibody discovery and development company that addresses conventional barriers to find optimal clinical candidates swiftly and efficiently. Its integrated platform combines diverse antibodies, expert selection, proprietary tools, and advanced data science to deliver developable leads quickly, setting partners up for long-term success.

COMPASS Pathways

Series B in 2020
COMPASS Pathways is a UK-based mental health care company dedicated to accelerating patient access to innovative treatments for mental health challenges. The company focuses on developing psilocybin therapy, administered in conjunction with psychological support, for patients with treatment-resistant depression who have not responded to conventional treatments.

Clara Health

Venture Round in 2020
Clara Health operates a software platform that facilitates participation in clinical trials for patients. Its technology enables users to discover and connect with relevant trials, streamlining the process from protocol design to site selection and adherence monitoring. The platform is designed to be patient-centric, allowing individuals to filter through available trials based on their specific needs and circumstances.

AbCellera

Series A in 2020
AbCellera is an antibody discovery and development company that addresses conventional barriers to find optimal clinical candidates swiftly and efficiently. Its integrated platform combines diverse antibodies, expert selection, proprietary tools, and advanced data science to deliver developable leads quickly, setting partners up for long-term success.

Emulate

Series D in 2020
Emulate is a biotechnology company that develops organ-on-a-chip human emulation technology to model how diseases, medicines, chemicals, and foods affect human health. Its platform includes lung, intestinal, liver, and skin organ chips that reproduce normal biology and disease states, enabling human-relevant insights beyond traditional cell culture or animal models. The company also provides drug development tools and instrumentation software to support research and development workflows for researchers across biotechnology, pharmaceutical, consumer health, cosmetics, chemical, food, and agrochemical sectors, as well as government agencies and academic institutions. Founded in 2013 and headquartered in Boston, Emulate aims to accelerate understanding of human biology and improve human health outcomes.

Sword Health

Series A in 2020
Sword Health specializes in digital health solutions for physical rehabilitation. It employs artificial intelligence to deliver personalized care globally, enabling patients to perform interactive exercises at home under remote physiotherapist supervision.

Q Bio

Series B in 2020
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Modern Health

Series B in 2020
Modern Health is a mental wellness platform designed for innovative companies to support the mental health of their employees. The platform offers a comprehensive suite of services including therapy sessions, coaching, and self-guided courses, all accessible through a user-friendly app. Modern Health combines the WHO well-being assessment with self-service wellness kits and connects users with certified coaches and licensed therapists in 35 languages. By providing these resources, Modern Health aims to destigmatize mental health conversations and make services more accessible, ultimately improving employee well-being and productivity.

Ostro

Series A in 2019
Ostro is a health platform based in Miami, Florida, founded in 2019, that specializes in personalized engagement solutions for the life sciences sector. The company focuses on creating informative connections between medicine producers and consumers, enhancing healthcare experiences for both patients and healthcare professionals. Ostro's platform streamlines the patient journey, offering services such as virtual consultations, logistics, regulatory compliance, and integrated payment solutions. By personalizing healthcare journeys, Ostro aims to boost engagement and improve the overall health outcomes for millions of individuals while delivering value to life sciences brands.

Remrise

Seed Round in 2019
Remrise, Inc. is a health and wellness company founded in 2018 and headquartered in San Francisco, California. The company specializes in personalized sleep aids that utilize drug-free, plant-based ingredients to enhance sleep quality. Customers begin their experience by taking a quiz that helps identify their specific sleep challenges, allowing Remrise to provide tailored sleep formulas. The key ingredients in these formulas include Reishi, Spine Date Seed, and L-Theanine. Additionally, Remrise offers a user-friendly application for tracking sleep patterns, helping individuals monitor their progress over time. The company focuses on integrating both Eastern and Western herbal traditions to support holistic health and improve overall well-being.

Eight Sleep

Series C in 2019
Eight Sleep is a pioneering sleep technology company that manufactures smart mattresses designed to optimize rest and improve overall health. Founded in 2014, the company's products include temperature-regulating mattresses, sleep trackers, and other accessories aimed at creating personalized, comfortable sleep environments.

Scanwell Health

Seed Round in 2019
Scanwell Health, Inc. is a healthcare company that specializes in at-home diagnostic solutions, focusing on urine testing kits. Founded in 2018 and headquartered in Los Angeles, California, Scanwell Health has developed an FDA-cleared urine testing application that allows users to obtain clinical-grade results via their smartphones. The company's flagship product is a urinary tract infection test kit that not only provides accurate testing results but also connects users with online medical professionals for same-day treatment and prescriptions. By combining innovative technology with accessible healthcare services, Scanwell Health aims to enhance proactive health management for individuals seeking convenient and affordable medical care.

Modern Animal

Seed Round in 2019
Modern Animal is a veterinary platform and clinic operator based in Los Angeles that combines in-clinic care with at-home services and a mobile app. The company provides general and preventive veterinary care, including wellness visits, vaccinations, parasite prevention, routine labs, dental care, and surgeries such as spays and mass removals, along with diagnostics like ultrasound and radiology, and nutritional and behavioral assessments. Through its platform, clients can access unlimited exams, 24/7 virtual care, in-app prescription requests and delivery, and flexible options such as walk-in and drop-off visits. The business supports a membership model designed to deepen relationships among doctors, pets and owners while leveraging technology and design to improve access, convenience and the overall pet-care experience.

Applied Molecular Transport

Series C in 2019
Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, focused on developing oral biologic product candidates to address autoimmune, inflammatory, metabolic, and other diseases. Utilizing its proprietary technology platform, the company aims to leverage natural cellular trafficking pathways for the efficient transport of therapeutics across the intestinal epithelium barrier. Its lead product candidate, AMT-101, is an oral gastrointestinal-selective interleukin 10 that has successfully completed a Phase 1b clinical trial for ulcerative colitis. Applied Molecular Transport is also advancing AMT-126, an oral fusion of rhIL-22 targeting intestinal epithelium barrier function defects. The company's pipeline includes various oral biologic modalities, such as peptides, proteins, antibodies, and RNA therapeutics, designed for both localized gastrointestinal treatment and systemic circulation, emphasizing patient-friendly tablet and capsule forms.

Sana Health

Convertible Note in 2019
Sana Health, Inc. is a digital health company based in Lafayette, Colorado, with an additional office in Mill Valley, California. Founded in 2015, the company specializes in developing bio-therapeutic devices designed to promote relaxation and alleviate pain and tension. Its flagship product, Sana, is a non-addictive mask and headphone combination that utilizes audiovisual stimulation to enhance the balance between the left and right sides of the brain, facilitating a deep meditative state. This device employs coordinated pulses of light and sound to guide users into relaxation, mimicking the benefits of long-term meditation practices. Sana Health is also engaged in multiple clinical studies, focusing on applications for conditions such as fibromyalgia and neuropathic pain, as well as trials related to anxiety and PTSD. The company offers its products for sale online and provides a mobile application accessible via major app platforms.

Earable Neuroscience

Seed Round in 2019
Earable Neuroscience is a deep tech company focusing on building consumer wearables and solutions that unlock human potential through improved sleep and cognitive function. Earable was early-invested in by FoundersFund and Samsung Ventures. After 9 years of R&D at the University of Colorado and the University of Oxford, Earable invented FRENZ Brainband - a pioneering AI-powered sleep-aid wearable designed to track and stimulate brain activity in real time using science-backed personalized audio delivered via bone-conduction speakers.

X-Vax

Series A in 2019
X-Vax Technology is a biotechnology company established in 2015 and headquartered in Jupiter, Florida. Its primary focus is the preclinical and clinical development of vaccines targeting mucosal infections caused by pathogens, including herpes, influenza, tuberculosis, and HIV, which affect millions globally. X-Vax is known for its development of a herpes vaccine candidate based on a genetically altered HSV-2 virus, specifically designed to elicit a robust immune response by inducing antibodies that lead to the killing of infected cells. This innovative approach utilizes Fc receptor activating antibodies that facilitate antibody-dependent cell-mediated killing, aiming to provide effective protection against herpes types 1 and 2. Through its pioneering research, X-Vax intends to advance the field of vaccines and enhance immune responses against significant viral infections.

Notable Labs

Series B in 2019
Notable Labs, Inc. is a clinical-stage company that specializes in personalized lab testing services for cancer patients, particularly those with brain cancer. Founded in 2014 and based in Foster City, California, the company utilizes its proprietary Predictive Precision Medicines Platform to conduct drug combination experiments on patients' tumors. This platform allows Notable Labs to simulate cancer treatments and predict patient responses to specific therapies, enabling healthcare providers to prioritize combinations of FDA-approved treatments that can be prescribed without the need for clinical trials. By providing detailed reports to physicians, Notable Labs aims to enhance treatment efficacy and expedite therapeutic development for patients.

Collective Health

Series E in 2019
Collective Health provides a cloud-based health benefits platform that unifies medical, dental, vision, pharmacy, and related programs into a single administration experience, helping employers simplify benefits, guide employees in understanding and navigating care, and manage costs and outcomes. The platform offers integrated administration of all health plans through one portal, with live concierge support and digital tools to find and manage care, and connects employees with medical, pharmacy, dental, and vision providers. Headquartered in San Francisco with offices in Chicago and Lehi, it aims to reduce the administrative burden of delivering benefits while improving member experience and overall health outcomes.

Flo Health

Series A in 2019
Flo Health is a company based in Redwood City, California, founded in 2015. It specializes in developing menstruation cycle tracking solutions through its flagship app, Flo. The app offers comprehensive support for girls and women throughout various stages of their reproductive lives, including menstruation, conception preparation, pregnancy, early motherhood, and menopause. Flo provides curated cycle and ovulation tracking, personalized health insights, expert tips, and a private community where users can share questions and concerns. The app is available in over 20 languages on both iOS and Android platforms, prioritizing safety and aiming to be a trusted digital source for women's health information.

Teckro

Series C in 2019
Founded in 2015, Teckro is a life science technology company based in Limerick, Ireland. It offers a solution that transforms clinical trials by instantly connecting all relevant stakeholders and sharing knowledge, reducing burden on study personnel. The company serves pharmaceutical companies and clinical researchers globally.

Ritual

Series B in 2019
Based in sunny Los Angeles, Ritual is a direct-to-consumer health brand that believes it’s crucial to know not just what you’re putting into your body, but why you need it in the first place. We’re transparent about our ingredients, where they're sourced from, and have spent years conducting extensive research behind each of the premium nutrient forms we use. Our products are simple, effective, and backed by science. Our mission is simple: to empower people to feel their best by turning healthy habits into a ritual. We have built a team of curious skeptics, world-class scientists, unconventional artists, expert marketers and analytical strategists that are on a mission to reinvent an entire industry. We’re well-funded, growing quickly, and committed to our mission. If you’re a team player who refuses to settle for the status quo, we want you. Welcome to your new daily Ritual.

Hims & Hers

Series C in 2019
Hims & Hers is a telehealth platform connecting consumers with licensed medical professionals for accessible, convenient healthcare. Initially focused on telemedicine services like erectile dysfunction and hair loss treatments, the company expanded to cover mental health, dermatology, primary care, and more.

Roivant Sciences

Private Equity Round in 2018
Roivant Sciences is a biopharmaceutical company dedicated to advancing the development of innovative late-stage drug candidates and enhancing healthcare delivery. The company aims to expedite the process of bringing new medicines to patients while reducing associated costs, thereby benefiting the healthcare system. Roivant achieves this by creating specialized entities known as "Vants," which are agile biotech and healthcare technology companies that leverage unique talent sourcing and incentive alignment strategies. In addition to its focus on biopharmaceuticals, Roivant incubates discovery-stage companies and health technology startups that complement its core business. Among its commercial-stage drug candidates is VTAMA, a treatment for plaque psoriasis in adults, along with several other candidates, including Batoclimab, IMVT-1402, Brepocitinib, and Namilumab, which are at various stages of development.

Siren Care

Series A in 2018
Siren Care develops wearable health technology for diabetic foot health monitoring. The company offers Siren diabetic socks and a foot temperature monitoring system that continuously tracks foot temperature to detect early signs of inflammation and diabetic foot ulcers, helping prevent complications such as amputations. Data from the socks can be accessed via a mobile application and shared with providers, including podiatrists, to support monitoring and timely intervention. It serves patients and healthcare providers through its flagship Siren Diabetic Foot Program. Founded in 2015 and based in San Francisco, Siren Care focuses on proactive foot health management for individuals at risk of diabetic foot complications.

Applied Molecular Transport

Series B in 2018
Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, focused on developing oral biologic product candidates to address autoimmune, inflammatory, metabolic, and other diseases. Utilizing its proprietary technology platform, the company aims to leverage natural cellular trafficking pathways for the efficient transport of therapeutics across the intestinal epithelium barrier. Its lead product candidate, AMT-101, is an oral gastrointestinal-selective interleukin 10 that has successfully completed a Phase 1b clinical trial for ulcerative colitis. Applied Molecular Transport is also advancing AMT-126, an oral fusion of rhIL-22 targeting intestinal epithelium barrier function defects. The company's pipeline includes various oral biologic modalities, such as peptides, proteins, antibodies, and RNA therapeutics, designed for both localized gastrointestinal treatment and systemic circulation, emphasizing patient-friendly tablet and capsule forms.

Contraline

Seed Round in 2018
Contraline, Inc. is a biotechnology company based in Charlottesville, Virginia, focused on developing innovative male birth control solutions. The company is pioneering the first long-lasting, non-hormonal, and reversible contraceptive for men. Its primary product, Echo-V, is an ultrasound-visible polymer solution that is injected into the vas deferens, forming a polymer hydrogel device. This device functions as a semi-permeable membrane, effectively blocking sperm while allowing bodily fluids to pass through. Contraline also offers Vasintomy, a non-surgical procedure for the insertion of Echo-V, providing a cost-effective and accessible approach to male contraception. Incorporated in 2015, Contraline aims to transform the landscape of reproductive health for men.

SmithRx

Series A in 2018
Founded in San Francisco in 2016, SmithRx specializes in designing and managing custom pharmacy benefit plans for companies. It leverages a modern technology platform to deliver flexibility, efficiency, and customer satisfaction, aligning incentives through data analytics.

Hubble Contacts

Venture Round in 2018
Hubble Contacts provides contact lenses and eyewear at affordable prices with a focus on simplicity and convenience. Originated to make eye care accessible to as many people as possible, it has evolved to include high-quality eyeglasses and sunglasses in its product lineup. The company emphasizes an easy, hassle-free shopping experience and strong customer service to reduce the typical friction of reordering lenses and selecting frames. Guided by a mission to improve accessibility and affordability in eye care, Hubble Contacts seeks to offer reliable products and responsive support through a dedicated team.

Hims & Hers

Series B in 2018
Hims & Hers is a telehealth platform connecting consumers with licensed medical professionals for accessible, convenient healthcare. Initially focused on telemedicine services like erectile dysfunction and hair loss treatments, the company expanded to cover mental health, dermatology, primary care, and more.

Cedar

Series B in 2018
Cedar is a patient payment and engagement platform designed for hospitals, health systems, and medical groups to enhance the overall patient experience. Founded in 2016 and headquartered in New York, the platform utilizes advanced data science to streamline and personalize the billing process. By consolidating billing information from various caregivers, Cedar provides clear invoices that detail patient obligations while offering user-friendly click-to-pay options. This modern approach not only simplifies the payment experience but also supports healthcare providers in improving their billing operations and fostering better patient engagement.

Emulate

Series C in 2018
Emulate is a biotechnology company that develops organ-on-a-chip human emulation technology to model how diseases, medicines, chemicals, and foods affect human health. Its platform includes lung, intestinal, liver, and skin organ chips that reproduce normal biology and disease states, enabling human-relevant insights beyond traditional cell culture or animal models. The company also provides drug development tools and instrumentation software to support research and development workflows for researchers across biotechnology, pharmaceutical, consumer health, cosmetics, chemical, food, and agrochemical sectors, as well as government agencies and academic institutions. Founded in 2013 and headquartered in Boston, Emulate aims to accelerate understanding of human biology and improve human health outcomes.

Indee Labs

Seed Round in 2018
Indee Labs develops hardware and platform technologies for gene delivery to immune cells, with the aim of enabling the rapid development and scalable manufacture of gene-modified cell therapies, including CAR-T cells. The company focuses on non-viral delivery methods to introduce small molecules, nucleic acids, proteins, and gene-editing complexes into immune cells, supporting biopharmaceutical research and manufacturing while maintaining high cell viability and function. Its technology has progressed with collaboration from national facilities and through participation in biotech incubators and accelerators. Indee Labs maintains an international footprint, with an office in Sydney and lab space in Berkeley, reflecting its cross-regional development and manufacturing focus.

Datavant

Venture Round in 2018
Datavant is a health data platform company focused on securely connecting and organizing biomedical data to support drug development and clinical trials. It provides a privacy-preserving network that enables the secure exchange of health records across thousands of organizations, helping researchers and pharmaceutical developers access real-world data while protecting patient privacy. By structuring data for trial design and interpretation, the company aims to improve clinical outcomes and accelerate medical research.

Siren Care

Seed Round in 2018
Siren Care develops wearable health technology for diabetic foot health monitoring. The company offers Siren diabetic socks and a foot temperature monitoring system that continuously tracks foot temperature to detect early signs of inflammation and diabetic foot ulcers, helping prevent complications such as amputations. Data from the socks can be accessed via a mobile application and shared with providers, including podiatrists, to support monitoring and timely intervention. It serves patients and healthcare providers through its flagship Siren Diabetic Foot Program. Founded in 2015 and based in San Francisco, Siren Care focuses on proactive foot health management for individuals at risk of diabetic foot complications.

Oscar Health

Venture Round in 2018
Oscar Health is a health insurance company based in New York, founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser. It specializes in offering individual and family health insurance plans, Medicare Advantage programs for seniors, and small group products. Oscar Health aims to enhance the healthcare experience by leveraging technology, design, and data to make services more accessible and user-friendly. The company primarily serves individuals, couples, and families who do not receive employer-sponsored health insurance in select states, including New York, New Jersey, California, and Texas. In addition to traditional insurance offerings, Oscar provides virtual care, doctor support, and appointment scheduling, emphasizing a comprehensive approach to healthcare management.

Collective Health

Series D in 2018
Collective Health provides a cloud-based health benefits platform that unifies medical, dental, vision, pharmacy, and related programs into a single administration experience, helping employers simplify benefits, guide employees in understanding and navigating care, and manage costs and outcomes. The platform offers integrated administration of all health plans through one portal, with live concierge support and digital tools to find and manage care, and connects employees with medical, pharmacy, dental, and vision providers. Headquartered in San Francisco with offices in Chicago and Lehi, it aims to reduce the administrative burden of delivering benefits while improving member experience and overall health outcomes.

SmithRx

Series A in 2018
Founded in San Francisco in 2016, SmithRx specializes in designing and managing custom pharmacy benefit plans for companies. It leverages a modern technology platform to deliver flexibility, efficiency, and customer satisfaction, aligning incentives through data analytics.

Uniform Teeth

Seed Round in 2018
Uniform Teeth is an orthodontics practice focused on delivering accessible and high-quality orthodontic care. The company operates dental clinics that utilize a modern approach to treatment, specializing in clear teeth aligners. These aligners are crafted from biocompatible, BPA-free plastic designed to fit snugly over the teeth at each stage of the orthodontic process. By prioritizing patient experience and innovative technology, Uniform Teeth aims to simplify the journey to achieving straightened teeth.

Cedar

Series A in 2017
Cedar is a patient payment and engagement platform designed for hospitals, health systems, and medical groups to enhance the overall patient experience. Founded in 2016 and headquartered in New York, the platform utilizes advanced data science to streamline and personalize the billing process. By consolidating billing information from various caregivers, Cedar provides clear invoices that detail patient obligations while offering user-friendly click-to-pay options. This modern approach not only simplifies the payment experience but also supports healthcare providers in improving their billing operations and fostering better patient engagement.

Counsyl

Venture Round in 2017
Counsyl is a health technology company specializing in DNA screening services for individuals and families. The company focuses on providing critical information that can significantly influence health outcomes, enabling proactive measures and informed decision-making. With a strong commitment to accessibility, Counsyl has screened over 500,000 patients and collaborated with more than 6,000 healthcare professionals through its accredited clinical laboratory. It employs sophisticated technology and custom robotic automation to analyze blood and saliva samples with precision and efficiency. The platform not only aids in family planning through its Family Prep Screen but also encompasses informed pregnancy and cancer screening. Recognized for its innovative approach, Counsyl has received accolades such as the Wall Street Journal’s Innovation Award for Medicine and has been listed among Scientific American's "Top 10 World Changing Ideas." The company combines the expertise of scientists, engineers, and clinical professionals to enhance communication between patients and healthcare providers regarding medical results.

Teckro

Series B in 2017
Founded in 2015, Teckro is a life science technology company based in Limerick, Ireland. It offers a solution that transforms clinical trials by instantly connecting all relevant stakeholders and sharing knowledge, reducing burden on study personnel. The company serves pharmaceutical companies and clinical researchers globally.

Hubble Contacts

Series A in 2017
Hubble Contacts provides contact lenses and eyewear at affordable prices with a focus on simplicity and convenience. Originated to make eye care accessible to as many people as possible, it has evolved to include high-quality eyeglasses and sunglasses in its product lineup. The company emphasizes an easy, hassle-free shopping experience and strong customer service to reduce the typical friction of reordering lenses and selecting frames. Guided by a mission to improve accessibility and affordability in eye care, Hubble Contacts seeks to offer reliable products and responsive support through a dedicated team.

Freenome

Series A in 2017
Freenome, Inc. is an artificial intelligence genomics biotech company based in South San Francisco, California, founded in 2014. The company focuses on developing accurate, accessible, and non-invasive blood tests for the early detection of cancer and treatment selection. Utilizing a proprietary multi-omics platform, Freenome employs advanced algorithms to analyze cell-free genomic data, which aids in identifying early-stage cancers and other diseases. This innovative approach aims to transform disease management by enabling timely interventions and proactive treatment strategies. In addition to its diagnostic solutions, Freenome also offers clinical research services to further advance cancer detection and management.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.